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ABSTRACT 
 Mutations in alpha-synuclein and leucine-rich repeat kinase 2 (LRRK2) have been 
implicated in the cause of Parkinson’s disease (PD). These two proteins have been the 
targets of a great deal of recent research that has transformed our understanding of this 
disorder. Recent research using C. elegans as a model species has shown that alpha-
synuclein expression and the LRRK2-G2019S mutation potentiate neurodegeneration 
similar to that seen in cases PD. Further exploration revealed that defects in autophagy of 
dopaminergic neurons may be the cause for the observed pathology.  
 In the current study, the confirmation of autophagy as a possible cause of 
pathology due to the expression of alpha-synuclein and the LRRK2-G2019S mutation is 
completed through the use of electron microscopy. We observed that large vacuoles had 
formed in the cephalic dopaminergic neurons of alpha-synuclein + LRRK2 transgenic 
samples not seen in wild-type samples. Further, large morphological changes in the nerve 
ring area of the transgenic nematodes were also observed that may implicate that alpha-
synuclein expression in conjunction with the LRRK2-G2019S mutation may have a  
widespread effect on many neurons that was not previously expected. 
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INTRODUCTION 
 
 In 1817, Dr. James Parkinson first described several clinical cases and symptoms 
of a disease that would later be named in his honor. In An Essay on the Shaking Palsy, he 
describes this shaking palsy or paralysis agitans as “[i]nvoluntary tremulous motion, with 
lessened muscular power, in parts not in action and even when supported […]” (1817) 
(Parkinson 1817). Today, Parkinson’s disease (PD) is the world’s second most common 
neurodegenerative disorder affecting an estimated 5 million people, and the number of 
people that will develop PD is expected to increase dramatically in the coming decades 
(Olanow et al. 2009).  
 
Symptoms 
 The four cardinal motor symptoms of PD are resting tremor, rigidity, postural 
instability, and bradykinesia (Jankovic 2008). Tremor at rest is the most common 
symptom of PD and is almost always prominent in the most distal part of an extremity 
(Jankovic 2008). Rigidity refers to increased resistance during the movement of a limb 
and may also be associated with pain (Jankovic 2008). This rigidity of the neck and truck 
often causes postural instability and deformities that usually occurs late in the disease 
(Jankovic 2008). Bradykinesia is the most characteristic clinical feature of PD and is 
characterized by slowness of movement that is the result of disorders of the basal ganglia 
(Jankovic 2008). Out of the four cardinal motor symptoms of PD, bradykinesia was 
found to correlate best with the degree of dopamine deficiency of the patient 
(Vingerhoets et al. 1997).  
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 Non-motor symptoms of PD are often underappreciated. They include autonomic 
dysfunction, neurobehavioral abnormalities, and sensory and sleep disorders (Zesiewicz 
et al. 2006). Autonomic dysfunction may include orthostatic hypotension and sweating 
dysfunction (Jankovic 2008). Neurobehavioral abnormalities refer to cognitive decline, 
and studies done by Hely et al. demonstrated that 48% of PD patients met the diagnostic 
criteria for dementia (2005). Sensory disorders such as olfactory dysfunction, oral pain, 
and genital pain are frequent but are often not recognized as symptoms of PD (Doty 
2007). Sleeping disorders include excessive daytime sleepiness and insomnia (Gjerstad et 
al. 2006). 
 
Pathology 
The neuropathology of PD consists of the degeneration of the dopaminergic 
neurons in the substantia negra, which is also responsible for the motor symptoms 
displayed in patients with PD (Fahn & Sulzer 2004). In addition, intracellular 
eosinophilic inclusions containing aggregations of the misfolded protein alpha-synuclein 
called Lewy bodies are observed in many of the surviving neurons (Del Tredici & Braak 
2012).  It is believed that the impairment of protein degradation systems, including the 
ubiquitin-proteasome system and/or the autophagy-lysosome pathway, leads to the 
aggregation of proteins resulting in the presence of Lewy bodies and ultimately 
neurodegeneration in PD (Pan et al. 2008) (Figure 1).   
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Figure 1 – Causes of protein aggregration directly or indirectly affecting the function of 
protein degradation systems ultimately leading to dopaminergic neuron death. (Figure 
taken from Pan et al., 2008) 
 
Leucine-Rich Repeat Kinase 2 (LRRK2) 
 While the role of genetic factors had long been considered insignificant in the 
etiology of PD, two papers published in 2006 describing the role of a mutation in the 
Rubinsztein, 2006), in this article we will focus on the ALP
and its unique role in Parkinson’s disease. We will also discuss
the putative therapeutic potential of autophagy upregulation.
Parkinson’s disease is one of the most common
neurodegenerative diseases in the elderly. Lewy bodies,
cytoplasmic inclusions that contain aggregated roteins a d
degeneration of substantia nigra dopamine neurons repre-
sent the pathological hallmarks of the disorder (Taylor
et al., 2000; Braak et al., 2003; Lansbury and Lashuel, 2006;
McNaught and Olanow, 2006). Increasing numbers of
proteins, such as !-synuclein, have been identified in Lewy
bodies, but their role in the pathogenesis of both sporadic
and familial Parkinson’s disease is not well understood
(Zarranz et al., 2004; Chua and Tang, 2006; Mizuta et al.,
2006). Mutations of !-synuclein, such as A53T, A30P and
E46K (Polymeropoulos et al., 1997; Kru¨ger et al., 1998;
Zarranz et al., 2004), and the increase of intracellular
concentrations of non-mutant !-synuclein, such as triplica-
tion of the !-synuclein gene, have been implicated in the
cause of the disorder (Singleton et al., 2003).
Beside excessive accumulation of misfolded proteins,
several lines of evidence have converged to suggest that
environmental neurotoxins, including herbicides, such as
paraquat, and other mitochondrial poisons, such as
rotenone, (Betarbet et al., 2000; Sherer et al., 2003),
mutant proteins such as DJ-1 (Bonifati et al., 2003),
PINK1 (Valente et al., 2004) and LRRK2 (West et al.,
2005), may contribute to mitochondrial dysfunction and
increase cellular oxidative stress, all of which have been
implicated in the aetiopathogenesis of Parkinson’s disease.
Increased oxidative stress, associated with depletion of ATP,
is considered to contribute to the reduction of proteasome
activity and aggregation of abnormal proteins (Norris and
Giasson, 2005; Abou-Sleiman et al., 2006; Lin and Beal,
2006; Schapira, 2006). Moreover, mutations of parkin
(Foroud et al., 2003; Kay et al., 2007) and UCH-
L1(Maraganore et al., 2004; Das et al., 2006), components
of the UPS and mutations of ATP13A2 that codes for a
lysosomal ATPase (Ramirez et al., 2006; Di Fonzo et al.,
2007) have also been shown to result in impaired protein
degradation. Thus, a failure of protein degradation caused
by various factors may lead to neuronal cell death related to
Parkinson’s disease and other neurodegenerative disorders
(Webb et al., 2003) (Fig. 1).
Protein clearance systems in Parkinson’s
disease
UPS
The UPS is responsible for a highly selective degradation of
short-lived intracellular and plasma membrane proteins
under basal metabolic conditions, as well as misfolded or
damaged proteins in the cytosol, nucleus or endoplasmic
reticulum. The system involves the targeting of susceptible
proteins by ubiquitin and only the unfolded ubiquitinated
proteins can pass through the narrow pore of the
proteasome barrel. Dysfunction of the UPS and the
Fig. 1 Causes of protein aggregation and dopaminergic neuron death. Multiple factors, such as genetics, aging and environmental toxins, or
combinations, have been implicated in the aetiology of Parkinson’s disease. All these may directly or indirectly affect the function of protein
degradation systems, including ubiquitin proteasome system (UPS) and autophagy-lysosome pathway (ALP), and thereby, cause the death of
dopamine neurons.
1970 Brain (2008), 131, 1969^1978 T. Pan et al.
 at Boston University Libraries on M
arch 3, 2013
http://brain.oxfordjournals.org/
Downloaded from 
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leucine-rich repeat kinase 2 (LRRK2) as a cause for autosomal dominant PD has shifted 
the focus of research regarding the etiology of PD towards genetics (Ozelius et al. 2006)	  
(Lesage et al. 2006)	  (Bonifati 2006). While the aforementioned cases of PD involve only 
a small subset of patients with PD, it has been shown that the same G2019S substitution 
in the LRRK2 gene commonly found in North African Arabs and Ashkenazi Jews with 
PD are also common in sporadic cases PD (Gilks et al. 2005).  It is currently the most 
common genetic cause of PD in Europe, accounting for ~7.14% of familial PD and ~4% 
of sporadic PD (Paisan-Ruiz 2009). 
 The LRRK2 gene encodes a 2,257-amino acid protein called dardarin and has 51 
exons (Paisan-Ruiz 2009). In addition to the G2019S mutation found in LRRK2, there 
have been many other variants discovered and these variants are shown in Figure 2. 
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 The physiological role of LRRK2 is currently unknown. However, research done 
by Tong et al. has shown that the loss of LRRK2 in mice dramatically increases apoptotic 
cell death, inflammatory responses, and oxidative damage in the kidney of the mice 
(2010). Although there was no finding of neurodegeneration in these mice, the increased 
alpha-synuclein and ubiquitinated protein aggregation and impairment of the autophagy-
lysosomal pathway that was also observed in the kidney of these mice might offer clues 
to how mutations in LRRK2 may cause PD (Tong et al. 2010). 
 
Caenorhabditis elegans (C. elegans) 
 The use of C. elegans as a model species for PD research has been invaluable. 
While the human brain has over 100 billion nerve cells interacting with one another, this 
nematode has 302 neurons for which a precise neuronal connectivity map exists 
(Caldwell & Caldwell 2008). In addition, its physical transparency, the short life span of 
about 2 weeks, and the ease of maintaining the worms make them an ideal model species 
for studying neurological disorders and aging (Caldwell & Caldwell 2008). C. elegans 
may also provide insight into the etiology of sporadic PD that is still inexplicably linked 
to environmental causes and age after studies have demonstrated that the worm is 
susceptible to toxins commonly used to model neurodegeneration (Nass et al. 2002).  Due 
to the evolutionary conservation of metazoan genomes, all orthologous genes related to 
familial PD with the exception of the gene encoding for alpha-synuclein have been 
identified in C. elegans genes (Caldwell & Caldwell 2008). The probability of 
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establishing therapeutic significance increases with these associations to the mammalian 
genome. 
 
Previous Experiments 
 Previous experiments done in the Wolozin lab have shown that an in vivo model 
using C. elegans expressing a mutant LRRK2 in association with alpha-synuclein 
potentiates neurodegeneration (Gowda et al. 2012). Green fluorescent protein expression 
studies of dopaminergic neuron activity in C. elegans models have shown that co-
expression of LRRK2-G2019S and alpha-synuclein lead to a decrease in dopaminergic 
neuron activity that can be observed as early as day 7 of the life of the nematode (Gowda 
et al. 2012). Further, an observation of the increase in Lgg-1, a requirement for the 
degradation of cellular components by autophagy in C. elegans, indicates that the 
resulting pathology may be caused by deficits in autophagy (Gowda et al. 2012).  
 Although Lgg-1 is a good indicator of autophagy in C. elegans, the gold standard 
method to confirm autophagy activity is transmission electron microscopy (Singletary & 
Milner 2008). The presence of double membrane vacuole structures that engulf 
cytoplasmic components is the strongest indicator that autophagy is occurring (Singletary 
& Milner 2008). The goal of this project is to find evidence of autophagy in the LRRK2-
G2019S alpha-synuclein transgenic C. elegans through the use of transmission electron 
microscopy. 
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METHODS 
 The C. elegans samples were prepared and mounted onto slotted copper grids at 
the Albert Einstein College of Medicine by the laboratory of David Hall, Ph. D. The high 
pressure freezing (HPF) procedure was used as described by Hall et al. (2012):  
 
1. Each sample underwent rapid freezing at high pressure (2100 bar) in a 
2% osmium tetroxide in 98% acetone and 2% water solution in order to 
preserve organelle structure. The HPF apparatus was programmed to 
hold the temperature at -90°C for 110 hours, warm slowly to -20°C 
(5°C/hour), and held at -20°C for 15 hours. Then, it was warmed to 0°C 
slowly (6°C/hour) and held at 0°C.  
2. The samples were rinsed in 100% acetone at 0°C for 20 minutes three 
times. 
3. The samples were removed from specimen carrier at room temperature 
and rinsed three times in 100% acetone for 20 minutes at room 
temperature. 
4. The samples were placed into a Pella Specimen Capsule and submerged 
in a one part resin, three parts acetone mixture in a capped shell vial. 
The setup was then placed on a rotator at room temperature for three 
hours. 
5. The mixture was changed to a 1:1 resin:acetone mixture and rotated for 
three hours at room temperature. 
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6. The mixture was changed to a 3:1 resin:acetone mixture and rotated for 
16 hours at room temperature. 
7. The mixture was changed to 100% resin four times over the next 24 
hours and rotated at room temperature. 
8. The samples were embedded between Aclar films or in an embedding 
mold and cured at 60°C for two days. 
 
The resin mixture used was composed of 24 g of Embed812, 9 g of dodecenylsuccinic 
anhydride (DDSA), 15 g of methyl-5-norbornene-2,3-dicarboxylic anhydride (NMA). 
The resin mixture was then stored at room temperature in a desiccator until ready for use. 
0.75 g of DMP-30 resin accelerator was added to the resin mixture only in steps that 
called for 100% resin. 
Each C. elegans sample was then sectioned serially using the Hartwieg Method as 
described by Hall et al. (2012). The block containing the sample was trimmed to a perfect 
trapezoid, where the longest side of the trapezoid is shorter than the width of the diamond 
tipped knife. Some sticky wax, Charette	  ASTM	  D4236	  that	  can found in graphics arts 
stores, was applied to the top and bottom of the trapezoid to allow the sections to remain 
adhered to each other after being cut. Thin sections were then cut to obtain a light gray to 
white color of the section. Continuous sections were then picked up by a coated slotted 
grid.  
Negative staining was completed after mounting on copper slotted grid using a 
2% uranyl acetate solution. This solution was filtered using a 0.2 µm syringe filter before 
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applying to the grid. After one minute of stain application, filter paper was used to draw 
off the stain, and the grid was left to dry for several hours. 
Imaging was completed using the Zeiss Libra 120 transmission electron 
microscope at the Harvard University Center for Nanoscale Systems. The samples were 
imaged at room temperature with a tungsten filament. The omega filter of the microscope 
was used when possible, and the acceleration voltage used was 80 kV.  
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RESULTS 
 The C. elegans samples from previous studies prepared for electron microscopy 
were imaged and analyzed to locate the cephalic dopaminergic neurons. Irregularities in 
the dopaminergic neurons were found in many samples such as the ones shown in figures 
3 and 4.  
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Figure 3 – Transmission electron microscope image of the right dorsal cephalic 
dopaminergic (CEPDR) neuron of an alpha-synuclein + LRRK2-G2019S transgenic C. 
elegans sample at 8000 times magnification. An unusually large vacuole is seen that is 
expected in these transgenic C. elegans samples due to errors in autophagy leading to an 
accumulation of cellular debris within the cell body of the neuron. Other smaller vacuoles 
are present, but it is unknown whether their presence is due to errors in autophagy due to 
their smaller size. 
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  Figure	  4	  -­‐	  A	  series	  of	  images	  depicting	  serial	  sections	  of	  a	  left	  dorsal	  cephalic	  (CEPDL)	  neuron	  of	  a	  transgenic	  C.	  elegans	  at	  8000x	  magnification.	  The	  neuron	  has	  developed	  a	  vacuole	  large	  enough	  to	  assume	  most	  of	  its	  internal	  space.	  	  	   Comparisons	  between	  images	  of	  a	  wild-­‐type	  CEPDR	  and	  an	  alpha-­‐synuclein	  +	  LRRK2-­‐G2019S	  transgenic	  CEPDR	  were	  also	  completed	  as	  shown	  in	  figure	  5.	  	  
              
 
Figure 5 – Comparison between wild-type and alpha-synuclein + LRRK2-G2019S 
transgenic CEPDR images of C. elegans at 8000x magnification. (a) The wild-type 
CEPDR neuron displays no discernible vacuoles within its cytoplasm. No abnormal 
phenotype is observed. Image adapted from (Thomson 2011a) (b) The transgenic CEPDR 
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neuron has developed empty spaces indicative of vacuoles that have developed mostly 
likely due to the LRRK2 mutation in association with alpha-synuclein expression. 
 
 Further comparisons between wild-type and transgenic C. elegans of the whole 
cross-section of the worm at the area where the nerve ring is found was done in order to 
observe the effects of the mutations in a holistic manner as seen in figure 6. There were 
significant morphological changes in the transgenic worm sample compared to the wild-
type worm. Large empty white spaces and areas of high electron density are seen in the 
transgenic nematode but not in wild-type. However, the muscular system of the 
transgenic worm appears to be similar to that of the wild-type worm.  
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Figure 6 – Comparison of electron microscope images of cross sections of whole 
nematode samples located around the nerve ring at 2000x magnification. The images 
have been rotated so that the dorsal side faces up in both images. (a) The image of the 
cross-section of the wild-type C. elegans displays no visible pathology. The pharyngeal 
valve is found in the center of the worm with its non-striated muscles. Striated muscles 
used for movement by the nematode are found along the edges of the cross-section. In the 
area in between these areas are the nerves of the nerve ring and their supporting cells. 
Image was adapted from (Thomson 2011b)  (b) The cross-section of the transgenic C. 
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elegans displays the pharyngeal valve, its muscles, and the striated muscles used for 
movement without any visible pathology. However, the area in between these areas is 
markedly different from that of the wild-type C. elegans. There are areas of white spaces 
and areas of very electron dense areas not observed in the wild-type cross section.   
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DISCUSSION 
 The results of previous studies in conjunction with this project suggest that 
defects in autophagy may play a critical role in the pathogenesis of PD. Further, recent 
research done on LRRK2-G2019S transgenic mice have shown similar defects in 
autophagy (Orenstein et al. 2013).  Strong evidence that disease-linked mutations in 
LRRK2, such as G2019S, impair catabolic activity within the neuron has also been found 
in flies (Hindle & Elliott 2013). Enhancement of toxic protein aggregates and alpha-
synuclein occurs as a result of this failure of autophagy eventually leading to the 
neurodegeneration seen in PD.  
 The comparison of the images of the cross-section of the whole nematode (figure 
6) reveals that the LRRK2-G2019S mutation in conjunction with alpha-synuclein 
expression may have an effect beyond the four sole dopaminergic neuron that was 
expected. While alpha-synuclein is known to be expressed in only dopaminergic neurons 
in humans (Lakso et al. 2003), its addition to C. elegans may have widespread unknown 
effects throughout the nerve ring. In addition, the widespread effects seen in the images 
of the transgenic C. elegans may be due to LRRK2-G2019S, a mutation with effects that 
are known to be widespread throughout many areas of the brain in humans (Paisan-Ruiz 
2009). This widespread effect in humans may affect the whole of the nerve ring within C. 
elegans in a similar manner to how pathology is caused in humans. Future imaging of 
transgenic C. elegans samples with only the alpha-synuclein expression and other 
samples with only the LRRK2-G2019S mutation should be completed to compare any 
differences in the resulting morphology. 
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 If further imaging of serial sections of C. elegans is completed, a 3-dimensional 
model of the neuronal cell body could be formed in order to further detail the effect that 
the LRRK2-G2019S mutation and alpha-synuclein expression has on the neuron and the 
nervous system as a whole. The detail from a 3-dimensional model could aid in the 
understanding of the pathophysiology of PD due to LRRK2-G2019S and/or alpha-
synuclein with more electron microscopy images of serial sections of more transgenic C. 
elegans. In addition, further electron microscopy imaging with immunostaining for Lewy 
bodies in transgenic C. elegans could be performed in order to better understand the 
progression of PD and add more detail to the 3-dimensional renders. 
 The limit of C. elegans as a model for imaging the effects of PD should be 
addressed. Because of the lack of endogenous alpha-synuclein expression in wild-type 
samples, its effects in transgenic samples must be closely examined in order to determine 
if the results are comparable to the pathology observed in humans or even higher species 
models such as mice. The use of zebrafish as models for recent PD studies have been 
successful and appear to be a good compromise between the accessibility and short 
generation time that C. elegans offers and the homology that Mus musculus offers.  
 The role of LRRK2 in autophagy is a strong focus for current research. Although 
the evidence for disease-linked mutations in LRRK2 impairing catabolic activity is great, 
the specific function of LRRK2 and the mechanism for its effects on autophagy are still 
largely unknown. The link between LRRK2 and alpha-synuclein should be explored 
further as well. It has been theorized that that the defects in autophagy linked to disease-
linked mutations of LRRK2 can ultimately lead to the alpha-synuclein protein 
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aggregation that is a key component of Lewy bodies . How these two proteins interact 
within the neuron is not well-understood, and future research in this area would allow a 
greater understanding of the pathogenesis of PD. 
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